» Articles » PMID: 1737996

Reserpine-induced Processing of Chromogranin A in Cultured Bovine Adrenal Chromaffin Cells

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 1992 Mar 1
PMID 1737996
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of reserpine on the processing of the secretory granule protein chromogranin A (CgA) in isolated bovine adrenal chromaffin cells was investigated using two radioimmunoassays employing site-specific antisera. The two antisera were directed against closely associated regions of the CgA molecule which would be exposed by specific processing: antiserum L331 was raised against the C-terminus of the regulatory peptide pancreastatin, and the second antiserum, L300, was raised against the synthetic peptide [Tyr0]CgA306-313 (YLSKEWEDA), a sequence that lies immediately C-terminal to pancreastatin and adjacent to a dibasic amino acid cleavage site. Chronic reserpine treatment of chromaffin cells produced a time- and dose-dependent increase in processing, as demonstrated by an increase in pancreastatin- and YLSKEWEDA-immunoreactivity (ir). The reserpine-induced rise in pancreastatin-ir was due predominantly to an increase in pancreastatin 1-47, whereas the rise in YLSKEWEDA-ir was due to increases in three polypeptides: a 51-kDa YLSKEWEDA-ir polypeptide, CgA297-313, and CgA248-313. The latter predominated. The action of reserpine on both pancreastatin- and YLSKEWEDA-ir was found to be largely inhibited by the protein synthesis inhibitor cycloheximide. The results show that treatment of isolated chromaffin cells with reserpine induces both the selective proteolytic processing and peptidyl-glycine amidation of CgA and its derived fragments. As reserpine has a similar effect on proenkephalin in chromaffin cells, the results suggest that reserpine induces a general increase in the activity of the processing enzymes, partially by an increase in protein synthesis.

Citing Articles

Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.

Blackmore C, Varro A, Dimaline R, Bishop L, Gallacher D, Dockray G J Physiol. 2001; 531(Pt 3):605-17.

PMID: 11251044 PMC: 2278512. DOI: 10.1111/j.1469-7793.2001.0605h.x.


Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.

Hussain I, Bate G, Henry J, Djali P, Dimaline R, Dockray G J Physiol. 1999; 517 ( Pt 2):495-505.

PMID: 10332097 PMC: 2269351. DOI: 10.1111/j.1469-7793.1999.00495.x.


Processing of chromogranins in chromaffin cell culture: effects of reserpine and alpha-methyl-p-tyrosine.

Wolkersdorfer M, Laslop A, Lazure C, Fischer-Colbrie R, Winkler H Biochem J. 1996; 316 ( Pt 3):953-8.

PMID: 8670175 PMC: 1217441. DOI: 10.1042/bj3160953.


The chromogranins A and B: the first 25 years and future perspectives.

Winkler H, Fischer-Colbrie R Neuroscience. 1992; 49(3):497-528.

PMID: 1501763 PMC: 7131462. DOI: 10.1016/0306-4522(92)90222-n.